Kazakhstan: COVID-19 vaccine enters clinical trials

Clinical trials of Kazakhstani QazCovid-in vaccine against the COVID-19 virus developed by the Scientific Research Institute for Biological Safety Problems have started, the Ministry of Education and Science reports. Adult volunteers aged 18-50 years old will be involved in the clinical trials. Phase 1 trials will define the vaccine’s safety on 44 volunteers free of…

Ukraine: Farmak to gradually exit lockdown

Private joint-stock company Farmak (Kyiv), the pharmaceutical company, did not halt production and would gradually exit lockdown, the press service of the company reported. “Farmak continues production as usual. All lines are working as planned. However, after lockdown was announced all over the country on March 12 and the Health Ministry recommended that enterprises transfer…